Immune factors involved in the cervical immune response in the HIV/HPV co-infection

Journal of Clinical Pathology

Volumn 61, Issue 1, 2008, Pages 84-88

  Nicol, Alcina F ^a   Nuovo, G J ^b   Salomao Estevez A ^a   Grinsztein, B ^c   Tristao A ^a   Russomano, F ^a   Lapa E Silva, J R ^d   Oliveira, M P ^a   Pirmez, C ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b University Hospital   (United States)

^c Funda??o Oswaldo Cruz   (Brazil)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INTERLEUKIN 10 RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NEF PROTEIN; RANTES; STAT3 PROTEIN; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR II; UNCLASSIFIED DRUG; PTGS1 PROTEIN, HUMAN; TUMOR PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD VESSEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUALITY CONTROL; UTERINE CERVIX; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS; CLINICAL TRIAL; ENZYME IMMUNOASSAY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; UTERINE CERVIX TUMOR; VIROLOGY;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHEMOKINE CCL5; CYCLOOXYGENASE 1; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; NEOPLASM PROTEINS; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 38449108456     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2007.047290     Document Type: Article

References (23)

1. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
2. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539-45.
3. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-67.
4. Aggarwal BB, Shishodia S, Sandur SK, et al. Inflammation and cancer: how hot is the link? Biochem Pharmacol 2006;72:1605- 21.
5. Guatelli JC, Gingeras TR, Richman DD. Alternative splice acceptor utilization during human immunodeficiency virus type 1 infection of cultured cells. J Virol 1990;64:4093-8.
6. Scully RE, Bonfiglio TA, Kurman RJ, et al. Histological typing of female genital tract tumours. World Health Organization - International histological classification of tumors. 2nd edn. Berlin: Springler-Verlag, 1994.
7. Nicol AF, Nuovo GJ. RT in situ PCR: protocols and applications. In: Savidge T, Charalabos P, eds. Methods in Microbiology. Vol. 34. London: Elsevier Academic Press, 2005:239-54.
8. Gulick R, Ribaudo HJ, Shikuma CM, et al. Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection. N Engl J Med 2004;350:1850-61.
9. Gaffney DK, Golden K, Zempolich K, et al. Elevated COX2 expression in cervical carcinoma. Am J Clin Oncol 2001;24:443-6.
10. Farley J, Uyehara C, Hashiro G, et al. Cyclooxygenase-2 expression predicts recurrence of cervical dysplasia following loop electrosurgical excision procedure. Gynecol Oncol 2004;92:596-602.
11. Sales KJ, Katz AA, Howard B, et al. Cyclooxygenase-1 is up regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors and angiogenic factors by cyclooxygenase-1. Cancer Res 2002;62:424-32.
12. Sarian LO, Derchain SF, Yoshida A, et al. Expression of cyclooxygenase-2 (COX-2) and Ki67 as related to disease severity and HPV detection in squamous lesions of the cervix. Gynecol Oncol 2006;102:537-41.
13. Adams DH, Lloyd A. Chemokine: leucocyte recruitment and activation cytokines. Lancet 1997;349:490-6.
14. Tedla N, Palladinetti P, Wakefield D, et al. Abundant expression of chemokines in malignant and infective human lymphadenopathies. Cytokine 1999;11:531-40.
15. Kleine-Lowinski K, Rheinwald JG, Fichorova RN, et al. Selective suppression of monocyte chemoattractant protein-1 expression by human papillomavirus E6 and E7 oncoproteins in human cervical epithelial and epidermal cells. Int J Cancer 2003;107:407-15.
16. Behbahani H, Walther-Jallow L, Klareskog E, et al. Proinflammatory and type 1 cytokine expression in cervical mucosa during HIV-1 and human papillomavirus infection. J Acquir Immune Defic Syndr 2007;45:9-19.
17. Guess JC, McCance DJ. Decreased migration of Langerhans precursor-like cells in response to human keratinocytes expressing human papillomavirus type 16 E6/E7 is related to reduced macrophage inflammatory protein-3alpha production. J Virol 2005;79:14852-62.
18. Alcocer-Gonzalez JM, Berumen J, Tamez-Guerra R, et al. In vivo expression of immunosuppressive cytokines in human papillomavirus- transformed cervical cancer cells. Viral Immunol 2006;19:481-91.
19. Niwa Y, Akamatsu H, Niwa H, et al. Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin Cancer Res 2001;7:285-9.
20. Stove V, de Walle IV, Naessens E, et al. Human immunodeficiency virus Nef induces rapid internalization of the T-cell coreceptor CD8αβ. J Virol 2005;79:11422-33.
21. Nicol AF, Fernandes ATG, Grinsztejn B, et al. Distribution of immune cell subsets and cytokine producing cells in the uterine cervix of human papillomavirus (HPV) infected women: Influence of HIV-1 co-infection. Diagn Mol Pathol 2005;14:39-47.
22. Naka T, Narazaki M, Hirata M, et al. Structure and function of a new STAT-induced STAT inhibitor. Nature 1997;387:924-9.
23. Nicol AF, Wang Y, Nuovo GJ, et al. In situ detection of SSI/SOCS and cytokine expression in the uterine cervix from HIV/HPV co-infected women. Exp Mol Pathol 2006;81:42-7.